Ignite Creation Date:
2024-05-05 @ 10:51 PM
Last Modification Date:
2024-10-26 @ 10:25 AM
Study NCT ID:
NCT01204255
Status:
COMPLETED
Last Update Posted:
2017-11-17
First Post:
2010-09-15
Brief Title:
Lorazepam Diphenhydramine Hydrochloride and Haloperidol Gel in Healthy Volunteers
Sponsor:
Virginia Commonwealth University
Organization:
Virginia Commonwealth University
Study Overview
Official Title:
Absorption of ABH Gel Ativan Lorazepam Benadryl Diphenhydramine and Haldol Haloperidol Gel From the Skin of Normal Volunteers
Status:
COMPLETED
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Lorazepam diphenhydramine hydrochloride and haloperidol gel when absorbed into the skin may be an effective treatment for nausea and vomitingPURPOSE This clinical trial studies lorazepam diphenhydramine hydrochloride and haloperidol gel in healthy volunteers
Detailed Description:
OBJECTIVESI To study the absorption of the three components in the topical ABH gel in 10 healthy volunteers and determine if there are any adverse effects OUTLINE Patients apply lorazepam diphenhydramine hydrochloride and haloperidol gel topically over 2 minutes After completion of study treatment patients are followed up for 5 hours
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2010-01968 | REGISTRY | None | None |
| PEP-10-174-1-PCSM | OTHER_GRANT | American Cancer Society | None |